Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lensar Inc (LNSR)

Lensar Inc (LNSR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 137,487
  • Shares Outstanding, K 11,945
  • Annual Sales, $ 53,490 K
  • Annual Income, $ -31,400 K
  • EBIT $ -20 M
  • EBITDA $ -16 M
  • 60-Month Beta 0.66
  • Price/Sales 2.57
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 86.12% (-73.51%)
  • Historical Volatility 53.22%
  • IV Percentile 21%
  • IV Rank 14.70%
  • IV High 449.41% on 11/17/25
  • IV Low 23.50% on 08/19/25
  • Expected Move (DTE 5) 2.13 (18.46%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 17
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 2,273
  • Open Int (30-Day) 2,289
  • Expected Range 9.39 to 13.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +153,792.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.46 +21.67%
on 11/17/25
11.69 -1.54%
on 12/12/25
+1.10 (+10.57%)
since 11/12/25
3-Month
9.46 +21.67%
on 11/17/25
12.83 -10.29%
on 09/18/25
-0.96 (-7.70%)
since 09/12/25
52-Week
7.13 +61.43%
on 12/16/24
17.31 -33.51%
on 03/19/25
+3.80 (+49.29%)
since 12/12/24

Most Recent Stories

More News
LENSAR® Reports Third Quarter 2025 Results and Provides Business Update

18 ALLY Robotic Cataract Laser Systems ® (“ALLY Systems”) placed in 3Q 2025; Backlog of 18 ALLY Systems pending installation as of September 30, 2025 ALLY installed base grew 77% and total...

LNSR : 11.51 (+0.09%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

LNSR : 11.51 (+0.09%)
LENSAR Reports Second Quarter 2025 Results and Provides Business Update

18 ALLY Robotic Cataract Laser Systems™ (“ALLY Systems”) placed in 2Q 2025 with an additional backlog of 18 ALLY Systems pending installation as of June 30, 2025 ALLY installed base grew 107%...

LNSR : 11.51 (+0.09%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 11.51 (+0.09%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 11.51 (+0.09%)
LENSAR Reports First Quarter 2025 Results and Provides Business Update

LNSR : 11.51 (+0.09%)
Alcon Agrees to Acquire LENSAR, Inc.

LNSR : 11.51 (+0.09%)
ALC : 78.80 (+0.05%)
LENSAR - Top Healthcare Equipment Stock

Summary LENSAR (LNSR) has shown strong technical buy signals, high Weighted Alpha, and consistent price appreciation, gaining 16.65% since the Trend Seeker buy signal on 2/28.. The company specializes...

LNSR : 11.51 (+0.09%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 11.51 (+0.09%)
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s total installed systems increased to approximately...

LNSR : 11.51 (+0.09%)

Business Summary

LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida.

See More

Key Turning Points

3rd Resistance Point 11.97
2nd Resistance Point 11.83
1st Resistance Point 11.67
Last Price 11.51
1st Support Level 11.37
2nd Support Level 11.23
3rd Support Level 11.07

See More

52-Week High 17.31
Fibonacci 61.8% 13.42
Fibonacci 50% 12.22
Last Price 11.51
Fibonacci 38.2% 11.02
52-Week Low 7.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar